Alex and Schnappauf explain how Vault CRM is a step-change for companies like Bayer, and discuss the benefits of being able ...

AstraZeneca and Daiichi Sankyo's Datroway (datopotamab deruxtecan) came out of the blocks strongly at the ESMO congress with ...

Insmed's DPP1 inhibitor Brinsupri (brensocatib) has been recommended by the CHMP for the treatment of patients aged 12 and ...

Akeso and Summit Therapeutics have shared the full data from the HARMONi-6 trial of PD-1xVEGF bispecific ivonescimab as a ...

Hevia and Soussa discuss the landscape of unmet needs in metastatic castration-resistant prostate cancer, what the new data ...

A wireless retinal implant has been shown to restore vision in patients with geographic atrophy (GA), a major cause of ...

Roche has taken a lead in the oral SERD category of breast cancer therapies with the presentation of new data at ESMO showing ...

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...

In an era where the biopharmaceutical landscape is rapidly evolving, a comprehensive approach to demonstrating and ...

Interestingly, while only 16% of oncology researchers reported using AI in biomarker detection and assessment at the time of ...

Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...

Karen Westaway is CEO of ValueBase. She is a health equity evangelist passionate about accelerating access to innovative ...